Table 2

Affinities of S18327 at multiple adrenergic receptors and NE reuptake sites

ReceptorSpeciesTissueRadioligandpKi
nM
α1 RatFrontal cortex[3H]Prazosin (0.2)8.95  ± 0.09
α1A RatSalivary gland[3H]Prazosin (0.04)8.88  ± 0.09
α1B RatLiver[3H]Prazosin (0.04)9.34  ± 0.03
α1A HumanCHO cell line[3H]Prazosin (0.1)9.00  ± 0.09
α1B HumanCHO cell line[3H]Prazosin (0.1)9.11  ± 0.08
α1D HumanCHO cell line[3H]Prazosin (0.1)8.56  ± 0.12
α2A RatCortex[3H]RX821002 (0.4)6.68  ± 0.04
α2A HumanSf9 cells[3H]MK912 (0.7)7.42  ± 0.02
α2A HumanCHO cell line[3H]RX821002 (0.8)7.07  ± 0.11
α2B HumanCHO cell line[3H]RX821002 (4.0)7.56  ± 0.13
α2C HumanCHO cell line[3H]RX821002 (0.6)7.30  ± 0.13
β1 HumanSf9 cells[3H]CGP12177 (0.16)<6
β2 HumanSf9 cells[3H]CGP12177 (0.2)<6
NE reuptake siteRatFrontal cortex[3H]Nisoxetine (1)<6
NE reuptake siteHumanCHO cell line[3H]Nisoxetine (2)<6

Data are means ± S.E. of ≥3 determinations performed in triplicate. For details of methods, see Millan et al., 1998b.